Belite Bio (BLTE) Return on Assets (2023 - 2026)

Belite Bio's (BLTE) quarterly Return on Assets came in at 0.8% in Q1 2026, up 99.0% year-on-year from 0.4% in Q1 2025, and up 33.21% quarter-over-quarter from 1.19% in Q4 2025.

Belite Bio (BLTE) Return on Assets (2023 - 2026) Analysis & Trends

Belite Bio's Return on Assets history runs 4 years deep, the most recent figure standing at 0.8% for Q1 2026.

  • On a quarterly basis, Return on Assets rose 99.0% year-over-year to 0.8% in Q1 2026; TTM through Mar 2026 was 0.8%, a 99.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
  • Return on Assets climbed to 0.8% in Q1 2026 per BLTE's latest filing, from 1.19% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.8% in Q1 2026 and bottomed at 3.21% in Q2 2023.
  • The 4-year median for Return on Assets is 2.19% (2025), against an average of 2.02%.
  • Biggest YoY gain for Return on Assets was 162 bps in 2024; the steepest drop was 89 bps in 2024.
  • Year by year, Return on Assets stood at 1.8% in 2023, then sank by 50 bps to 2.7% in 2024, then jumped by 56 bps to 1.19% in 2025, then jumped by 33 bps to 0.8% in 2026.
  • Per Business Quant, the three latest BLTE Return on Assets figures stand at 0.8% (Q1 2026), 1.19% (Q4 2025), and 2.19% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.69%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -0.01%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -0.80%
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 0.00%
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.80%
Dec 31, 2025 -1.19%
Sep 30, 2025 -2.19%
Jun 30, 2025 -2.19%
Mar 31, 2025 -1.79%
Dec 31, 2024 -2.70%
Sep 30, 2024 -2.22%
Jun 30, 2024 -1.58%
Mar 31, 2024 -1.50%
Dec 31, 2023 -1.80%
Sep 30, 2023 -2.32%
Jun 30, 2023 -3.21%
Mar 31, 2023 -2.78%